{"hands_on_practices": [{"introduction": "The Baltimore classification provides a powerful framework based on how a virus generates messenger RNA ($mRNA$). This first exercise challenges you to apply this principle to a classic virological paradox: the poxviruses. By analyzing why these double-stranded DNA (dsDNA) viruses are placed in Group $I$ despite replicating entirely in the cytoplasm, you will reinforce the core logic of the classification system and appreciate the remarkable enzymatic autonomy that some viruses have evolved [@problem_id:2478302].", "problem": "A research seminar challenges students to reconcile why poxviruses, which replicate entirely in the cytoplasm, are nevertheless placed in Baltimore Group $I$. You are asked to select the best justification grounded in first principles, using only the following foundational bases: (i) the Central Dogma of molecular biology (Deoxyribonucleic Acid (DNA) to Ribonucleic Acid (RNA) to protein via transcription to messenger RNA (mRNA) and translation), and (ii) the core definition of the Baltimore classification (grouping viruses by genome type and the route to mRNA, not by cellular location of replication). In your reasoning, identify how poxviruses generate mature, translatable mRNAs without accessing the host nucleus, including any specialized features needed to substitute for host nuclear functions such as capping and polyadenylation. Which option most accurately explains both why poxviruses are Group $I$ and what specialized apparatus enables their cytoplasmic exception?\n\nA. Poxviruses are Baltimore Group $I$ because they have a double-stranded DNA genome and produce mRNAs by transcription using a viral DNA-dependent RNA polymerase; the classification is based on genome type and route to mRNA, not subcellular location. They solve the absence of host nuclear machinery by encoding and packaging a multi-subunit DNA-dependent RNA polymerase, virion-associated early transcription factors, and a complete capping and polyadenylation apparatus, including an RNA $5'$ triphosphatase, a guanylyltransferase, an mRNA cap N7-methyltransferase, a $2'$-O-methyltransferase, and a poly(A) polymerase, enabling co-transcriptional capping and $3'$ polyadenylation entirely in the cytoplasm.\n\nB. Poxviruses are not truly Group $I$; their cytoplasmic replication implies they must use reverse transcription and thus belong to Group $VII$. They generate mRNA caps by cap-snatching from host mRNAs, analogous to orthomyxoviruses, thereby avoiding the need for viral capping enzymes.\n\nC. Poxviruses remain in Group $I$ because they recruit host RNA polymerase II from the nucleus into the cytoplasm and rely on relocalized host capping and polyadenylation enzymes; hence they do not encode dedicated transcription or capping machinery.\n\nD. Poxvirus classification is driven by virion morphology and envelope status rather than genome information flow, and their exception arises because they carry a simple, single-subunit bacteriophage-like RNA polymerase; capping is performed by host guanylyltransferase transiently exported to the cytoplasm.\n\nE. Poxviruses are Group $I$ solely due to their double-stranded DNA genomes; since cytoplasmic ribosomes can initiate translation on uncapped RNAs, they do not require a capping enzyme and therefore avoid the need for specialized transcription factors or poly(A) polymerase.", "solution": "The validity of the problem statement must first be established.\n\n**Step 1: Extraction of Givens**\n- **Virus Type**: Poxviruses.\n- **Key Feature**: Replicate entirely in the cytoplasm.\n- **Classification**: Baltimore Group $I$.\n- **Task**: Reconcile cytoplasmic replication with Group $I$ classification.\n- **Mandatory Principles for Reasoning**:\n    1.  The Central Dogma of molecular biology: Deoxyribonucleic Acid ($DNA$) $\\rightarrow$ Ribonucleic Acid ($RNA$) $\\rightarrow$ protein, via transcription to messenger RNA ($mRNA$) and translation.\n    2.  The core definition of the Baltimore classification system: Grouping viruses by genome type and their specific route to generating $mRNA$, irrespective of the subcellular location of replication.\n- **Specific Question**: Identify the mechanism by which poxviruses generate mature, translatable $mRNAs$ (including capping and polyadenylation) without access to the host cell nucleus and its machinery.\n\n**Step 2: Validation of Givens**\nThe problem statement rests on several core premises:\n1.  Poxviruses are large, enveloped viruses with a double-stranded DNA ($dsDNA$) genome. This is factually correct.\n2.  Poxviruses replicate exclusively in the cytoplasm of host cells. This is a defining and well-documented characteristic of the Poxviridae family.\n3.  The Baltimore classification system categorizes viruses based on the nature of their genome and the pathway to $mRNA$ synthesis. This is the correct definition of the system.\n4.  Group $I$ of the Baltimore classification includes viruses with $dsDNA$ genomes. This is correct. The canonical pathway for Group $I$ viruses is the transcription of the $dsDNA$ genome into $mRNA$.\n5.  Eukaryotic transcription and $mRNA$ processing (capping, polyadenylation) are typically nuclear events performed by host enzymes. This is a fundamental principle of eukaryotic molecular biology.\n\nThe problem poses a genuine and classic paradox in virology: how does a $dsDNA$ virus, which according to the general rule should utilize the host's nuclear machinery, manage to replicate entirely in the cytoplasm? The problem is scientifically grounded, well-posed, internally consistent, and requires a solution based on established biological facts. It is not ambiguous, trivial, or based on unsound science.\n\n**Step 3: Verdict and Action**\nThe problem statement is **valid**. The solution will now be derived based on the provided principles.\n\n**Derivation of the Solution**\nAccording to the problem's constraints, the reasoning must be grounded in the definition of the Baltimore classification and the Central Dogma.\n\n1.  **Classification in Baltimore Group $I$**: The Baltimore classification is based on the flow of genetic information from the viral genome to $mRNA$. Group $I$ is defined for viruses with a $dsDNA$ genome. The pathway to $mRNA$ for this group is direct transcription: $dsDNA \\xrightarrow{\\text{transcription}} mRNA$. Poxviruses possess a $dsDNA$ genome. They produce their $mRNA$ through transcription of this genome. Therefore, by stringent application of the classification rules, they belong in Group $I$. The location of replication (cytoplasm versus nucleus) is not a primary criterion for this classification scheme. This resolves the first part of the problem.\n\n2.  **Mechanism of Cytoplasmic Transcription and mRNA Maturation**: The central challenge for a poxvirus is that its cytoplasmic location denies it access to the host's nuclear machinery for:\n    a) Transcription of $DNA$ into $RNA$, which is performed by the host's DNA-dependent RNA polymerase II (DdRP II).\n    b) Processing of pre-$mRNA$ into mature $mRNA$, which includes the addition of a $5'$ cap and a $3'$ poly(A) tail by host nuclear enzymes.\n\n    To overcome this, poxviruses must be autonomous with respect to these functions. The virus has evolved to carry its own complex machinery to perform these tasks in the cytoplasm. The infectious poxvirus particle (virion) is not merely a container for the genome; it is a sophisticated molecular machine that packages a substantial payload of enzymes. Upon infection and uncoating in the cytoplasm, the viral core releases:\n    - A multi-subunit, virally-encoded **DNA-dependent RNA polymerase (vDdRP)**. This enzyme is responsible for transcribing the viral genes.\n    - **Early transcription factors**, also packaged in the virion, which are required to initiate transcription of the early class of viral genes.\n    - A complete **mRNA processing apparatus** that functions co-transcriptionally. This includes:\n        - **RNA triphosphatase**: Removes the terminal phosphate from the $5'$ end of the nascent $mRNA$.\n        - **Guanylyltransferase**: Adds a guanosine monophosphate residue to form the cap structure.\n        - **mRNA cap methyltransferases**: One enzyme, an **N7-methyltransferase**, methylates the added guanine nucleotide, and another, a **$2'$-O-methyltransferase**, methylates the adjacent sugar, forming a mature cap structure (Cap-1).\n        - **Poly(A) polymerase**: Synthesizes the poly(A) tail at the $3'$ end of the transcript.\n\n    This entire viral \"transcription factory\" allows the poxvirus to produce mature, capped, and polyadenylated $mRNAs$ entirely within the cytoplasm, ready for translation by host ribosomes. This strategy of genetic and enzymatic self-sufficiency is the solution to the paradox of a cytoplasmic $dsDNA$ virus.\n\n**Evaluation of Options**\n\n*   **A**: This option states that poxviruses are Group $I$ due to their $dsDNA$ genome and transcriptional pathway to $mRNA$, noting that location is irrelevant to the classification. It then correctly and comprehensively lists the packaged viral machinery: a multi-subunit DdRP, transcription factors, and the full enzymatic cascade for capping (triphosphatase, guanylyltransferase, methyltransferases) and polyadenylation. This aligns perfectly with the established biological facts and the derivation above. **Correct**.\n\n*   **B**: This option claims poxviruses belong to Group $VII$ (reverse transcribing viruses) and use cap-snatching. Both claims are factually incorrect. Poxviruses are Group $I$ viruses and they synthesize their $mRNA$ caps de novo; they do not \"snatch\" them from host $mRNAs$. **Incorrect**.\n\n*   **C**: This option incorrectly suggests that poxviruses recruit host RNA polymerase II and other processing enzymes from the nucleus. Poxviruses are notable precisely because they do *not* depend on these host nuclear components and instead encode their own. **Incorrect**.\n\n*   **D**: This option makes three incorrect assertions. First, it mischaracterizes the Baltimore system as being based on morphology. Second, it incorrectly describes the complex poxvirus RNA polymerase as a \"simple, single-subunit bacteriophage-like\" enzyme. The poxvirus polymerase is a large, complex, multi-subunit enzyme akin to eukaryotic polymerases. Third, it incorrectly attributes capping to a host enzyme. **Incorrect**.\n\n*   **E**: This option incorrectly claims that poxvirus $mRNAs$ are uncapped and that capping is not required for translation. Poxvirus $mRNAs$ are capped, and the virus expends significant genetic resources to encode the machinery to do so. While some viruses use IRES elements for cap-independent translation, this is not the strategy for poxviruses, whose $mRNAs$ rely on a conventional $5'$ cap for efficient translation. The claim that they avoid needing transcription factors or a poly(A) polymerase is also false. **Incorrect**.\n\nBased on a rigorous analysis, Option A is the only one that provides a scientifically accurate and complete explanation for both the classification of poxviruses and their unique cytoplasmic replication strategy.", "answer": "$$\\boxed{A}$$", "id": "2478302"}, {"introduction": "Moving from established principles to practical application, this next problem simulates the work of a virologist characterizing a novel isolate. You will be given two crucial experimental results and asked to deduce the virus's likely Baltimore group. This practice is designed to sharpen your deductive reasoning, forcing you to connect fundamental viral replication strategies to tangible experimental outcomes like drug sensitivity and enzymatic activities [@problem_id:2478308].", "problem": "A virology team isolates a novel virus from an environmental sample and performs two orthogonal functional assays immediately upon purification. First, when cells are infected in the continuous presence of actinomycin D at a concentration of $1\\,\\mu\\mathrm{g/mL}$ (a dose verified to abolish host deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) synthesis), robust production of viral proteins and progeny virions proceeds with kinetics indistinguishable from untreated controls. Second, detergent-permeabilized, nuclease-protected purified virions synthesize discrete capped RNA transcripts in vitro in the absence of any added cellular factors, and this activity is abolished by selective inhibition of RNA-dependent RNA polymerase (RdRP), but not by inhibitors of DNA-dependent RNA polymerases or reverse transcriptase.\n\nUsing as fundamental bases the Central Dogma of Molecular Biology ($\\mathrm{DNA}\\rightarrow\\mathrm{RNA}\\rightarrow\\mathrm{Protein}$), the absence of cellular RNA-dependent RNA polymerase activity in uninfected eukaryotic cells, and the mechanistic action of actinomycin D as a DNA intercalator that blocks DNA-templated transcription, infer which Baltimore classification group(s) of viruses are consistent with these two findings. Choose all that apply and justify your inference by explicitly linking each experimental observation to the minimal replication requirements implied by the viral genome type and the need for a virion-associated polymerase.\n\nA. Group $\\mathrm{III}$: double-stranded RNA viruses\n\nB. Group $\\mathrm{IV}$: positive-sense single-stranded RNA viruses\n\nC. Group $\\mathrm{V}$: negative-sense single-stranded RNA viruses\n\nD. Group $\\mathrm{VI}$: positive-sense single-stranded RNA viruses with a DNA intermediate (retroviruses)\n\nE. Group $\\mathrm{VII}$: double-stranded DNA viruses with an RNA intermediate (pararetroviruses)", "solution": "The problem statement poses a deductive exercise in virology, requiring the classification of a novel virus based on two experimental results. I shall first validate the problem statement itself, then proceed to a rigorous, step-by-step logical inference.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n\n1.  **Experimental Finding 1:** Viral infection in the presence of actinomycin D ($1\\,\\mu\\mathrm{g/mL}$) results in robust production of viral proteins and progeny virions with kinetics indistinguishable from untreated controls.\n2.  **Experimental Finding 2:** Detergent-permeabilized, nuclease-protected purified virions synthesize capped RNA transcripts in vitro without any added cellular factors. This activity is abolished by a selective RNA-dependent RNA polymerase (RdRP) inhibitor, but not by inhibitors of DNA-dependent RNA polymerases or reverse transcriptase.\n3.  **Fundamental Principles:**\n    *   Central Dogma of Molecular Biology: $\\mathrm{DNA}\\rightarrow\\mathrm{RNA}\\rightarrow\\mathrm{Protein}$.\n    *   Actinomycin D is a DNA intercalator that blocks DNA-templated transcription.\n    *   Uninfected eukaryotic cells lack RNA-dependent RNA polymerase (RdRP) activity.\n\n**Step 2: Validate Using Extracted Givens**\n\nThe problem is scientifically grounded. The Baltimore classification system is a cornerstone of virology. The experimental assays described—use of actinomycin D to probe for DNA-dependent transcription and in-virion polymerase assays—are standard, canonical techniques in the field. The provided mechanisms of action and cellular properties are factually correct. The problem is well-posed, providing sufficient information to deduce a limited set of possibilities. It is objective and free of ambiguity.\n\n**Step 3: Verdict and Action**\n\nThe problem statement is **valid**. I will proceed with the solution.\n\n### Derivation of Solution\n\nThe solution requires a systematic analysis of the implications of each experimental finding, using the provided principles to eliminate Baltimore classification groups that are inconsistent with the data.\n\n**Analysis of Experimental Finding 1: Resistance to Actinomycin D**\n\nThe first experiment establishes the effect of actinomycin D. This drug is stated to function by intercalating into DNA and inhibiting DNA-dependent RNA synthesis (transcription). The observation that viral protein synthesis and virion production are completely unaffected by a concentration of actinomycin D sufficient to abolish host transcription leads to a critical conclusion: **the synthesis of viral messenger RNA (mRNA) does not depend on a DNA template.**\n\nThis single fact allows for the immediate elimination of several Baltimore groups:\n*   **Group I (dsDNA viruses) and Group II (ssDNA viruses):** These viruses use a DNA genome (or synthesize a DNA intermediate) that must be transcribed by a DNA-dependent RNA polymerase to produce mRNA. This process would be inhibited by actinomycin D.\n*   **Group VI (Retroviruses, (+)ssRNA-RT):** These viruses use reverse transcriptase to convert their RNA genome into a dsDNA provirus, which integrates into the host genome. This DNA provirus is then transcribed by the host's DNA-dependent RNA polymerase II to produce viral mRNAs and new genomes. This transcription step is sensitive to actinomycin D.\n*   **Group VII (Pararetroviruses, dsDNA-RT):** These viruses have a dsDNA genome that is transcribed by the host's DNA-dependent RNA polymerase II into an RNA pregenome. This transcription step is also sensitive to actinomycin D.\n\nTherefore, Experimental Finding 1 restricts the possibilities to RNA viruses whose replication cycle does not involve a DNA intermediate. This leaves **Group III (dsRNA), Group IV ((+)ssRNA), and Group V ((-)ssRNA)** viruses.\n\n**Analysis of Experimental Finding 2: Virion-Associated RNA-Dependent RNA Polymerase**\n\nThe second experiment provides information about the enzymatic machinery contained within the purified virion. The key observations are:\n1.  Purified virions contain an enzyme capable of synthesizing RNA.\n2.  The enzyme is an RNA-dependent RNA polymerase (RdRP), confirmed by inhibitor specificity.\n3.  The enzyme is packaged within the virion, as it is protected from nucleases and functions without external cellular factors.\n\nThe biological rationale for a virus to package its own polymerase is that its genome, upon entry into a host cell, cannot be immediately utilized by the host's machinery to produce the necessary viral proteins, including the polymerase itself. Eukaryotic cells lack RdRP activity. Therefore, if the incoming viral genome cannot serve directly as an mRNA for translation by host ribosomes, the virus must bring its own RdRP to perform the initial transcription step.\n\nLet us evaluate the remaining candidate groups based on this principle:\n*   **Group IV ((+)ssRNA viruses):** The genome of these viruses is a positive-sense single-stranded RNA. By definition, this molecule has the same polarity as mRNA and can be directly translated by the host cell's ribosomes upon infection. The first proteins synthesized include the viral RdRP. Because the host can immediately translate the genome, there is no requirement for a pre-packaged polymerase in the virion. This is inconsistent with Finding 2.\n*   **Group III (dsRNA viruses):** The genome is a double-stranded RNA molecule. Host ribosomes cannot translate dsRNA. Therefore, the virus must use a virion-packaged RdRP to transcribe the dsRNA genome, producing (+)-sense mRNA transcripts that can then be translated. This is perfectly consistent with Finding 2.\n*   **Group V ((-)ssRNA viruses):** The genome is a negative-sense single-stranded RNA molecule, which is complementary to mRNA and cannot be translated by host ribosomes. The virus must use a virion-packaged RdRP to transcribe its (–)-ssRNA genome into (+)-sense mRNA transcripts for translation. This is also perfectly consistent with Finding 2.\n\n**Conclusion**\n\nSynthesizing the results from both experiments, we conclude that the virus must belong to a group that is insensitive to actinomycin D and is obligated to package an RdRP in its virion. These criteria are met by Group III and Group V viruses, but not by any other group.\n\n### Option-by-Option Analysis\n\n**A. Group $\\mathrm{III}$: double-stranded RNA viruses**\nThis group uses an RNA-based replication strategy, rendering it insensitive to actinomycin D (consistent with Finding 1). It must package an RdRP to transcribe its dsRNA genome into mRNA (consistent with Finding 2).\n**Verdict: Correct**\n\n**B. Group $\\mathrm{IV}$: positive-sense single-stranded RNA viruses**\nThis group is insensitive to actinomycin D (consistent with Finding 1). However, its genome is directly translatable, so it is not required to package an RdRP in the virion. This contradicts Finding 2.\n**Verdict: Incorrect**\n\n**C. Group $\\mathrm{V}$: negative-sense single-stranded RNA viruses**\nThis group uses an RNA-based replication strategy, rendering it insensitive to actinomycin D (consistent with Finding 1). Its genome is not translatable, so it must package an RdRP to synthesize mRNA (consistent with Finding 2).\n**Verdict: Correct**\n\n**D. Group $\\mathrm{VI}$: positive-sense single-stranded RNA viruses with a DNA intermediate (retroviruses)**\nThis group's replication cycle involves transcription from an integrated DNA provirus, a step that is sensitive to actinomycin D. This contradicts Finding 1.\n**Verdict: Incorrect**\n\n**E. Group $\\mathrm{VII}$: double-stranded DNA viruses with an RNA intermediate (pararetroviruses)**\nThis group's replication cycle involves transcription from its DNA genome, a step that is sensitive to actinomycin D. This contradicts Finding 1.\n**Verdict: Incorrect**\n\nThe analysis demonstrates that the observed experimental results are consistent only with viruses from Group III and Group V.", "answer": "$$\\boxed{AC}$$", "id": "2478308"}, {"introduction": "The viral replication machinery at the heart of the Baltimore system has profound quantitative consequences for viral evolution. This final exercise shifts focus from qualitative classification to quantitative analysis, focusing on the error-prone nature of the RNA-dependent RNA polymerase ($RdRP$) common to many RNA viruses. By applying principles of probability, you will calculate the mutation frequency for a model RNA virus, gaining a concrete understanding of how replication fidelity shapes the genetic diversity and evolutionary potential of a viral population [@problem_id:2478378].", "problem": "An RNA virus classified in the Baltimore system as a negative-sense single-stranded RNA (ssRNA) virus (Group V) replicates its genome using an RNA-dependent RNA polymerase (RdRP). In such viruses, replication proceeds without high-fidelity proofreading, and empirical measurements support modeling base misincorporation events at different nucleotide positions as independent Bernoulli trials. Let the per-nucleotide mutation probability be $\\mu$ and the genome length be $L$ nucleotides. Assume independence of errors across sites within a single replication cycle, and that at most one substitution can occur at a given site per replication. Using the definitions that the expected count of events in a sum of independent Bernoulli trials equals the sum of the expectations of the individual indicator variables, and that the probability of observing zero events across independent trials equals the product of the individual zero-event probabilities, derive expressions for the expected number of point mutations introduced per replication and for the probability that a newly synthesized genome is error-free. Then evaluate these expressions for $\\mu = 10^{-4}$ and $L = 10^{4}$. Round both numerical results to four significant figures, and express both quantities as dimensionless decimals (not percentages).", "solution": "The problem statement is submitted for validation.\n\nStep 1: Extract Givens\n- Virus classification: negative-sense single-stranded RNA (ssRNA) virus (Group V)\n- Replication model: base misincorporation events at different nucleotide positions are modeled as independent Bernoulli trials.\n- Per-nucleotide mutation probability: $\\mu$\n- Genome length: $L$ nucleotides\n- Assumption: Independence of errors across sites within a single replication cycle.\n- Assumption: At most one substitution can occur at a given site per replication.\n- Definition 1: The expected count of events in a sum of independent Bernoulli trials equals the sum of the expectations of the individual indicator variables.\n- Definition 2: The probability of observing zero events across independent trials equals the product of the individual zero-event probabilities.\n- Task 1: Derive the expression for the expected number of point mutations per replication.\n- Task 2: Derive the expression for the probability that a newly synthesized genome is error-free.\n- Task 3: Evaluate these expressions for $\\mu = 10^{-4}$ and $L = 10^{4}$.\n- Task 4: Round numerical results to four significant figures.\n- Task 5: Express results as dimensionless decimals.\n\nStep 2: Validate Using Extracted Givens\nThe problem is scientifically grounded. The modeling of mutation events in RNA viruses, which lack proofreading mechanisms, as independent Bernoulli trials is a standard and well-accepted first-order approximation in quantitative virology and molecular evolution. The parameter values provided ($\\mu = 10^{-4}$, $L = 10^{4}$) are realistic for this class of viruses. The problem is well-posed, providing all necessary definitions, variables, and assumptions required to derive a unique solution. The language is objective and precise. The problem does not violate any of the criteria for invalidity. It is self-contained, consistent, and formalizable.\n\nStep 3: Verdict and Action\nThe problem is valid. A complete solution will be provided.\n\nThe process of genome replication is modeled as a sequence of $L$ independent Bernoulli trials, where $L$ is the genome length. Each trial corresponds to the replication of a single nucleotide position.\n\nFirst, we derive the expression for the expected number of point mutations, denoted as $E[M]$.\nLet $X_i$ be an indicator random variable for a mutation event at the $i$-th nucleotide position, for $i = 1, 2, ..., L$. By definition of a Bernoulli trial, $X_i$ takes the value $1$ if a mutation occurs and $0$ otherwise.\nThe probability of a mutation at a single site is given as $\\mu$. Thus, the probability distribution for $X_i$ is:\n$$ P(X_i = 1) = \\mu $$\n$$ P(X_i = 0) = 1 - \\mu $$\nThe expected value of a single indicator variable $X_i$ is, by definition:\n$$ E[X_i] = 1 \\cdot P(X_i = 1) + 0 \\cdot P(X_i = 0) = 1 \\cdot \\mu + 0 \\cdot (1 - \\mu) = \\mu $$\nThe total number of mutations, $M$, in the newly synthesized genome is the sum of the mutations at each position:\n$$ M = \\sum_{i=1}^{L} X_i $$\nUsing the property of linearity of expectation, which holds for any sum of random variables regardless of their independence, the expected total number of mutations is the sum of the individual expectations. This aligns with the first definition provided in the problem statement.\n$$ E[M] = E\\left[\\sum_{i=1}^{L} X_i\\right] = \\sum_{i=1}^{L} E[X_i] $$\nSince $E[X_i] = \\mu$ for all $i$, this sum becomes:\n$$ E[M] = \\sum_{i=1}^{L} \\mu = L\\mu $$\nThis is the analytical expression for the expected number of point mutations per replication.\n\nSecond, we derive the probability that a newly synthesized genome is error-free, which we denote as $P_0$.\nAn error-free genome corresponds to the event that no mutations occur at any of the $L$ positions. This means that for all $i \\in \\{1, 2, ..., L\\}$, the outcome is $X_i = 0$.\n$$ P_0 = P(X_1 = 0 \\text{ and } X_2 = 0 \\text{ and } \\dots \\text{ and } X_L = 0) $$\nThe problem states that the misincorporation events are independent across sites. Therefore, the probability of the joint event is the product of the probabilities of the individual events, which aligns with the second definition provided.\n$$ P_0 = \\prod_{i=1}^{L} P(X_i = 0) $$\nThe probability of no mutation at a single site is $P(X_i = 0) = 1 - \\mu$.\n$$ P_0 = \\prod_{i=1}^{L} (1 - \\mu) = (1 - \\mu)^{L} $$\nThis is the analytical expression for the probability of an error-free replication.\n\nFinally, we evaluate these two expressions for the given parameter values: $\\mu = 10^{-4}$ and $L = 10^{4}$.\n\nThe expected number of mutations is:\n$$ E[M] = L\\mu = (10^{4}) \\times (10^{-4}) = 1 $$\nTo express this to four significant figures as required, we write $1.000$.\n\nThe probability of an error-free genome is:\n$$ P_0 = (1 - \\mu)^{L} = (1 - 10^{-4})^{10^{4}} = (1 - 0.0001)^{10000} = (0.9999)^{10000} $$\nThis expression is of the form $(1 - 1/n)^n$ with $n = 10^{4}$. As $n \\to \\infty$, this expression famously converges to $1/e$. For $n = 10^{4}$, the value is very close to this limit.\n$$ P_0 \\approx \\frac{1}{e} \\approx 0.36787944... $$\nCalculating the exact value:\n$$ P_0 = (0.9999)^{10000} \\approx 0.36786104... $$\nRounding this numerical result to four significant figures gives $0.3679$.\n\nThe two required numerical results are $1.000$ and $0.3679$.", "answer": "$$\\boxed{\\begin{pmatrix} 1.000 & 0.3679 \\end{pmatrix}}$$", "id": "2478378"}]}